Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Yang C, Boyson CA, Di Liberto M, Huang X, Hannah J, Dorn DC, et al. CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity. Cancer Res. 2015;75(9):1838-45.

Boysen G, Barbieri CE, Prandi D, Blattner M, Chae S-, Dahija A, et al. SPOP mutation leads to genomic instability in prostate cancer. Elife. 2015;4.

Alinari L, Mahasenan KV, Yan F, Karkhanis V, Chung J-, Smith EM, et al. Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation. Blood. 2015;125(16):2530-43.

Labbé DP, Zadra G, Ebot EM, Mucci LA, Kantoff PW, Loda M, et al. Role of diet in prostate cancer: the epigenetic link. Oncogene. 2015;34(36):4683-91.

Roma AA, Goyal A, Yang B. Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions. Int J Gynecol Pathol. 2015;34(5):480-6.

Rabadan R, Inghirami G. JAK-STAT in lymphoproliferative disorders. Oncoscience. 2015;2(9):737-8.

Martin NE, Gerke T, Sinnott JA, Stack EC, Andrén O, Andersson S-, et al. Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer. Mol Cancer Res. 2015;13(10):1431-40.

Graff RE, Pettersson A, Lis RT, DuPre N, Jordahl KM, Nuttall E, et al. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer. Prostate. 2015;75(9):897-906.

Farooqui M, Bohrer LR, Brady NJ, Chuntova P, Kemp SE, C Wardwell T, et al. Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival. Mol Cancer. 2015;14:138.

Alagesan B, Contino G, Guimaraes AR, Corcoran RB, Deshpande V, Wojtkiewicz GR, et al. Combined MEK and PI3K inhibition in a mouse model of pancreatic cancer. Clin Cancer Res. 2015;21(2):396-404.